Induction of apoptosis by the inhibitors of poly(ADP-ribose)polymerase in HeLa cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11010-008-9894-2.pdf
Reference46 articles.
1. D’Amours D, Denoyers S, D’Silva I et al (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342:249–268. doi: 10.1042/0264-6021:3420249
2. Cleaver JE, Morgan WF (1991) Poly(ADP-ribose)polymerase: a perplexing participant in cellular responses to DNA breakage. Mutat Res 257:1–18
3. Virag L, Szabo C (2002) The therapeutic potential of poly(ADP-ribose)polymerase inhibitors. Pharmacol Rev 54:375–429. doi: 10.1124/pr.54.3.375
4. Tentori L, Portarena I, Graziani G (2002) Potential clinical applications of poly(ADP-ribose)polymerase (PARP) inhibitors. Pharmacol Res 45:73–85. doi: 10.1006/phrs.2001.0935
5. Chalmers AJ (2004) Poly(ADP-ribose)polymerase-1 and inonizing radiation: sensor, signaling and therapeutic target. Clin Oncol 16:29–39. doi: 10.1016/S0936-6555(03)00223-1
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. p38 MAPK inhibitor SB203580 enhances anticancer activity of PARP inhibitor olaparib in a synergistic way on non-small cell lung carcinoma A549 cells;Biochemical and Biophysical Research Communications;2023-08
2. Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension;Pulmonary Pharmacology & Therapeutics;2023-06
3. Induction of apoptosis by ethanolic extract of leaf of Dillenia pentagyna Roxb. in A549 cells via NF-κB pathway;Phytomedicine Plus;2023-02
4. Resveratrol as a potential therapeutic molecule against neuropathy: A new narrative;Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders;2023
5. Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene Expression;Molecular Cancer Research;2022-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3